CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia
- PMID: 9687393
- PMCID: PMC105719
- DOI: 10.1128/AAC.42.8.1980
CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia
Abstract
At a children's hospital in Riga, Latvia, isolates identified as Salmonella typhimurium were found to be resistant to expanded-spectrum cephalosporins. Two of the resistant strains were analyzed for the mechanism of cephalosporin resistance. Isoelectric focusing revealed a common beta-lactamase with a pI of 8.8. In addition, one of the strains produced a pI 7.6 beta-lactamase. A transconjugant producing only the pI 7.6 enzyme was susceptible to expanded-spectrum cephalosporins; therefore, this enzyme was most likely SHV-1. Transformants producing only the pI 8.8 beta-lactamase were resistant to cefotaxime and aztreonam but were susceptible or intermediate to ceftazidime. A substrate profile determined spectrophotometrically with purified enzyme revealed potent activity against cefotaxime, with a relative kcat value of 95 (benzylpenicillin equal to 100). The enzyme showed lower relative kcat values for ceftazidime (3.3) and aztreonam (9.3). In addition, the enzyme was inhibited by clavulanate, sulbactam and tazobactam, with 50% inhibitory concentrations of 19, 100, and 3.4 nM, respectively. These results indicated the presence of an unusual extended-spectrum beta-lactamase. The gene expressing the pI 8.8 beta-lactamase was cloned. Nucleotide sequencing revealed a beta-lactamase gene that differs from the gene encoding CTX-M-2, which also originated from S. typhimurium, by 11 nucleotides, 4 of which result in amino acid substitutions: Ala27Thr, Val230Gly, Glu254Ala, and Ile278Val. These results indicated the presence of a novel extended-spectrum beta-lactamase, designated CTX-M-5, that specifically confers resistance to cefotaxime.
Figures
Similar articles
-
Two novel plasmid-mediated cefotaxime-hydrolyzing beta-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium.FEMS Microbiol Lett. 1998 Aug 15;165(2):289-93. doi: 10.1111/j.1574-6968.1998.tb13159.x. FEMS Microbiol Lett. 1998. PMID: 9742701
-
Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A beta-lactamase (CTX-M-4): involvement of serine 237 in cephalosporin hydrolysis.Antimicrob Agents Chemother. 1998 May;42(5):1259-62. doi: 10.1128/AAC.42.5.1259. Antimicrob Agents Chemother. 1998. PMID: 9593162 Free PMC article.
-
TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli.Antimicrob Agents Chemother. 2000 Apr;44(4):997-1003. doi: 10.1128/AAC.44.4.997-1003.2000. Antimicrob Agents Chemother. 2000. PMID: 10722503 Free PMC article.
-
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.Can J Microbiol. 2004 Mar;50(3):137-65. doi: 10.1139/w03-111. Can J Microbiol. 2004. PMID: 15105882 Review.
-
Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases.Front Mol Biosci. 2018 Feb 23;5:16. doi: 10.3389/fmolb.2018.00016. eCollection 2018. Front Mol Biosci. 2018. PMID: 29527530 Free PMC article. Review.
Cited by
-
Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain.Antimicrob Agents Chemother. 2001 Feb;45(2):616-20. doi: 10.1128/AAC.45.2.616-620.2001. Antimicrob Agents Chemother. 2001. PMID: 11158766 Free PMC article.
-
Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type beta-lactamase.J Clin Microbiol. 2003 Dec;41(12):5530-6. doi: 10.1128/JCM.41.12.5530-5536.2003. J Clin Microbiol. 2003. PMID: 14662935 Free PMC article.
-
Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 beta-lactamase production.Antimicrob Agents Chemother. 2003 Mar;47(3):1165-8. doi: 10.1128/AAC.47.3.1165-1168.2003. Antimicrob Agents Chemother. 2003. PMID: 12604564 Free PMC article.
-
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.Clin Microbiol Rev. 2001 Oct;14(4):933-51, table of contents. doi: 10.1128/CMR.14.4.933-951.2001. Clin Microbiol Rev. 2001. PMID: 11585791 Free PMC article. Review.
-
Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment.Clin Microbiol Rev. 2004 Apr;17(2):311-22. doi: 10.1128/CMR.17.2.311-322.2004. Clin Microbiol Rev. 2004. PMID: 15084503 Free PMC article. Review.
References
-
- Barthélémy M, Péduzzi J, Bernard H, Tancrède C, Labia R. Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum β-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca. Biochim Biophys Acta. 1992;1122:15–22. - PubMed
-
- Bauernfeind A, Casellas J M, Goldberg M, Holley M, Jungwirth R, Mangold P, Röhnisch T, Schweighart S, Wilhelm R. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection. 1992;20:158–163. - PubMed
-
- Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection. 1990;18:294–298. - PubMed
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous